Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative
PaperCitations, authors & open-access status
Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 52 citations, 2018 year and green oa status.
52
Citations
2018
Year
green
OA Status